Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Preliminary results
Director departure
Quarterly results
CC transcript
|
|
ANGIODYNAMICS INC (ANGO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2018 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within Okta, Great Lakes Dredge & Dock, MDC Partners, Colfax, Heritage-Crystal Clean, and AngioDynamics ?? New Research Emphasizes Economic Growth |
| 04/04/2018 |
GN
| Recent Analysis Shows Multi-Color, Madrigal Pharmaceuticals, SPX, AngioDynamics, Atara Biotherapeutics, and Quanex Building Products Market Influences — Renewed Outlook, Key Drivers of Growth |
| 09/28/2017 |
GN
| AngioDynamics Reports Fiscal 2018 First Quarter Results |
| 09/14/2017 |
GN
| Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open |
| 09/14/2017 |
GN
| AngioDynamics to Report Fiscal 2018 First Quarter Financial Results |
| 09/13/2017 |
GN
| AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference |
| 08/29/2017 |
GN
| AngioDynamics to Present at the 2017 Morgan Stanley Global Healthcare Conference |
| 07/18/2017 |
GN
| AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results |
| 07/07/2017 |
GN
| AngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results |
| 06/07/2017 |
GN
| AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System |
| 05/31/2017 |
GN
| AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access |
| 04/20/2017 |
GN
| AngioDynamics to Present at the 41st Annual Deutsche Bank Health Care Conference |
| 04/06/2017 |
GN
| AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders |
| 04/06/2017 |
GN
| AngioDynamics Announces Secondary Offering of 2.35 Million Shares of Common Stock by Selling Stockholders |
| 03/30/2017 |
GN
| AngioDynamics Reports Fiscal 2017 Third Quarter Results |
| 03/08/2017 |
GN
| AngioDynamics to Present at the Barclays Global Healthcare Conference |
| 10/08/2012 |
GN
| AngioDynamics Reports Fiscal 2013 First Quarter Financial Results |
| 10/08/2012 |
GN
| AngioDynamics to Acquire Vortex Medical |
| 10/05/2012 |
GN
| AngioDynamics Awarded GPO Contract for Vascular Access Products |
| 10/04/2012 |
GN
| AngioDynamics Awarded $16.5 Million Judgment in Case Against biolitec Inc. |
| 09/27/2012 |
GN
| AngioDynamics Bolsters Senior Leadership Team With Key Appointments |
| 09/21/2012 |
GN
| AngioDynamics to Report Fiscal 2013 First Quarter Financial Results and Hold Conference Call on October 8, 2012 |
| 09/05/2012 |
GN
| AngioDynamics to Present at the 10th Annual CL King Best Ideas Conference |
| 08/29/2012 |
GN
| AngioDynamics Earns FDA Clearance for First Vascular Access Product With BioFlo Technology to Reduce Catheter-Related Thrombus |
| 08/09/2012 |
GN
| AngioDynamics to Present at the 32nd Annual Canaccord Growth Conference |
| 07/12/2012 |
GN
| AngioDynamics Reports Fiscal 2012 Fourth Quarter and Full Year Financial Results |
| 07/03/2012 |
GN
| AngioDynamics to Report Fiscal 2012 Fourth Quarter and Full Year Financial Results and Hold Conference Call on July 12, 2012 |
| 07/02/2012 |
GN
| Journal of the American College of Surgeons Publishes Study on Using the NanoKnife(R) System to Treat Liver Tumors Adjacent to Blood Vessels |
| 05/22/2012 |
GN
| AngioDynamics Completes Acquisition of Navilyst Medical |
| 05/21/2012 |
GN
| AngioDynamics Appoints Experienced Industry Executive as Chief Technology Officer |
| 05/15/2012 |
GN
| AngioDynamics Shareholders Approve Share Issuance for Navilyst Medical Acquisition |
| 04/23/2012 |
GN
| AngioDynamics Resumes NanoKnife(R) System Shipments in the U.S. |
| 04/04/2012 |
GN
| AngioDynamics Reports Fiscal 2012 Third Quarter Financial Results |
| 03/21/2012 |
GN
| AngioDynamics to Report Fiscal 2012 Third Quarter Financial Results and Hold Conference Call on April 4, 2012 |
|
|
|